Loading...
•
Sep 30, 2022
Chemours Q3 2022 Earnings Report
Chemours reported mixed Q3 2022 results with strong performance in APM and TSS segments offset by headwinds in Titanium Technologies, amid macroeconomic uncertainty.
Key Takeaways
Chemours reported a 6% year-over-year increase in net sales to $1.8 billion for Q3 2022. Net income was $240 million, resulting in an EPS of $1.52. Adjusted EBITDA decreased by 2% year-over-year to $363 million. The APM and TSS segments delivered strong results, while the Titanium Technologies segment faced headwinds.
Net Sales increased by 6% year-over-year to $1.8 billion.
Net Income reached $240 million, with an EPS of $1.52.
Adjusted EBITDA was $363 million, a decrease of 2% year-over-year.
Free Cash Flow amounted to $229 million.
Revenue by Segment
Forward Guidance
Chemours expects Adjusted EBITDA for FY 2022 to be between $1.40 billion and $1.45 billion and Free Cash Flow to be greater than $575 million.
Positive Outlook
- Best assets
- Best team
- Best strategy
- Continue to deliver strong performance through the economic cycle
- Create value for our stakeholders
Challenges Ahead
- Macroeconomic uncertainty
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...